On ECHEMI
Home > Drugs > Hainan Poly Pharm. Co., Ltd.
Hainan Poly Pharm. Co., Ltd.
  • Founded in:

    1992-07-14
  • Country:

    China China
  • Address:

    Guilinyang Economic Development Zone, Meilan District, Haikou City
  • Tax NO.:

    91460000620000247L
  • Registered Funds:

    448.350021 million yuan
  • Website:

  • Email:

Related Drugs
Nimodipine for injection
Name Description Content CAS NO. Registered Holders
Nimodipine

Extract from the above information

More

Extract from the above information

66085-59-4 18
Dobutamine Hydrochloride Injection
The main ingredient and chemical name of this product are: 4-[2-[[1-methyl-3-(4-hydroxyphenyl)propyl]amino]ethyl]-1,2-benzenediol hydrochloride
Name Description Content CAS NO. Registered Holders
4-[2-[[1-methyl-3-(4-hydroxyphenyl)propyl]amino]ethyl]-1,2-benzenediol hydrochloride

1. It has a positive inotropic effect on the myocardium, mainly acting on β1 receptors, and has relatively little effect on β2 and α receptors. 2. It can directly excite cardiac β1 receptors to enhance myocardial contraction and increase stroke volume, thereby increasing cardiac output. 3. It can reduce peripheral vascular resistance (reduced afterload), but systolic blood pressure and pulse pressure generally remain unchanged, or only increase due to increased cardiac output. 4. It can reduce ventricular filling pressure and promote atrioventricular node conduction. 5. Myocardial contractility is enhanced, and coronary blood flow and myocardial oxygen consumption often increase. 6. Due to increased cardiac output, renal blood flow and urine volume often increase.

More

1. It has a positive inotropic effect on the myocardium, mainly acting on β1 receptors, and has relatively little effect on β2 and α receptors. 2. It can directly excite cardiac β1 receptors to enhance myocardial contraction and increase stroke volume, thereby increasing cardiac output. 3. It can reduce peripheral vascular resistance (reduced afterload), but systolic blood pressure and pulse pressure generally remain unchanged, or only increase due to increased cardiac output. 4. It can reduce ventricular filling pressure and promote atrioventricular node conduction. 5. Myocardial contractility is enhanced, and coronary blood flow and myocardial oxygen consumption often increase. 6. Due to increased cardiac output, renal blood flow and urine volume often increase.

0
Centella asiatica tablets
The main ingredient is Centella asiatica total glucosides.
Name Description Content CAS NO. Registered Holders
Clotrimazole

23593-75-1 46
Centella asiatica tablets
The main ingredient is Centella asiatica total glucosides.
Name Description Content CAS NO. Registered Holders
Clotrimazole

23593-75-1 46
Centella asiatica tablets
The main ingredient is Centella asiatica total glucosides.
Name Description Content CAS NO. Registered Holders
Clotrimazole

Not clearly described

More

Not clearly described

23593-75-1 46
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.